T2 Biosystems Inc
NASDAQ:TTOO
T2 Biosystems Inc
NASDAQ:TTOO
Price:
3.72 USD
1.92%
Market Closed
Updated:
May 4, 2024
T2 Biosystems Inc
Revenue
|
T2 Biosystems Inc
Revenue Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
T2 Biosystems Inc
NASDAQ:TTOO
|
Revenue
$7.2m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
39%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
T2 Biosystems Inc
Revenue Breakdown
Breakdown by Geography
T2 Biosystems Inc
T2 Biosystems Inc
Not Available
Breakdown by Segments
T2 Biosystems Inc
T2 Biosystems Inc
|
Total Revenue:
7.2m
USD
|
|
Product:
6.8m
USD
|
|
Product Consumables:
4.8m
USD
|
|
Product Instruments:
1.3m
USD
|
|
Service:
476k
USD
|
|
Contribution Revenue:
423k
USD
|
|
Instrument Rentals:
124k
USD
|
See Also
What is T2 Biosystems Inc's Revenue?
Revenue
7.2m
USD
7.2m
USD
Based on the financial report for Dec 31, 2023, T2 Biosystems Inc's Revenue amounts to 7.2m USD.
What is T2 Biosystems Inc's Revenue growth rate?
Revenue CAGR 10Y
39%
39%
Over the last year, the Revenue growth was -68%. The average annual Revenue growth rates for T2 Biosystems Inc have been -27% over the past three years , -7% over the past five years , and 39% over the past ten years .
You don't have any saved screeners yet
